236 related articles for article (PubMed ID: 26637184)
41. Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis.
Wolswijk G; Balesar R
Brain; 2003 Jul; 126(Pt 7):1638-49. PubMed ID: 12805111
[TBL] [Abstract][Full Text] [Related]
42. Sodium channel expression within chronic multiple sclerosis plaques.
Black JA; Newcombe J; Trapp BD; Waxman SG
J Neuropathol Exp Neurol; 2007 Sep; 66(9):828-37. PubMed ID: 17805013
[TBL] [Abstract][Full Text] [Related]
43. Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis.
Saikali P; Antel JP; Pittet CL; Newcombe J; Arbour N
J Immunol; 2010 Nov; 185(10):5693-703. PubMed ID: 20926794
[TBL] [Abstract][Full Text] [Related]
44. Localisation of citrullinated proteins in normal appearing white matter and lesions in the central nervous system in multiple sclerosis.
Bradford CM; Ramos I; Cross AK; Haddock G; McQuaid S; Nicholas AP; Woodroofe MN
J Neuroimmunol; 2014 Aug; 273(1-2):85-95. PubMed ID: 24907905
[TBL] [Abstract][Full Text] [Related]
45. Insulin-like growth factor binding proteins: regulation in chronic active plaques in multiple sclerosis and functional analysis of glial cells.
Chesik D; De Keyser J; Glazenburg L; Wilczak N
Eur J Neurosci; 2006 Sep; 24(6):1645-52. PubMed ID: 17004928
[TBL] [Abstract][Full Text] [Related]
46. A role for hypertrophic astrocytes and astrocyte precursors in a case of rapidly progressive multiple sclerosis.
Morcos Y; Lee SM; Levin MC
Mult Scler; 2003 Aug; 9(4):332-41. PubMed ID: 12926837
[TBL] [Abstract][Full Text] [Related]
47. Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease.
Bigl M; Brückner MK; Arendt T; Bigl V; Eschrich K
J Neural Transm (Vienna); 1999; 106(5-6):499-511. PubMed ID: 10443553
[TBL] [Abstract][Full Text] [Related]
48. Pharmacological Blockade of Cannabinoid CB1 Receptors in Diet-Induced Obesity Regulates Mitochondrial Dihydrolipoamide Dehydrogenase in Muscle.
Arrabal S; Lucena MA; Canduela MJ; Ramos-Uriarte A; Rivera P; Serrano A; Pavón FJ; Decara J; Vargas A; Baixeras E; Martín-Rufián M; Márquez J; Fernández-Llébrez P; De Roos B; Grandes P; Rodríguez de Fonseca F; Suárez J
PLoS One; 2015; 10(12):e0145244. PubMed ID: 26671069
[TBL] [Abstract][Full Text] [Related]
49. [The evidence for primary axonal loss in multiple sclerosis].
Anthony DC; Hughes P; Perry VH
Rev Neurol; 2000 Jun 16-30; 30(12):1203-8. PubMed ID: 10935251
[TBL] [Abstract][Full Text] [Related]
50. White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis.
Cambron M; D'Haeseleer M; Laureys G; Clinckers R; Debruyne J; De Keyser J
J Cereb Blood Flow Metab; 2012 Mar; 32(3):413-24. PubMed ID: 22214904
[TBL] [Abstract][Full Text] [Related]
51. Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions.
Van Doorn R; Van Horssen J; Verzijl D; Witte M; Ronken E; Van Het Hof B; Lakeman K; Dijkstra CD; Van Der Valk P; Reijerkerk A; Alewijnse AE; Peters SL; De Vries HE
Glia; 2010 Sep; 58(12):1465-76. PubMed ID: 20648639
[TBL] [Abstract][Full Text] [Related]
52. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
Krumbholz M; Theil D; Cepok S; Hemmer B; Kivisäkk P; Ransohoff RM; Hofbauer M; Farina C; Derfuss T; Hartle C; Newcombe J; Hohlfeld R; Meinl E
Brain; 2006 Jan; 129(Pt 1):200-11. PubMed ID: 16280350
[TBL] [Abstract][Full Text] [Related]
53. Brain glucose metabolism in an animal model of depression.
Detka J; Kurek A; Kucharczyk M; Głombik K; Basta-Kaim A; Kubera M; Lasoń W; Budziszewska B
Neuroscience; 2015 Jun; 295():198-208. PubMed ID: 25819664
[TBL] [Abstract][Full Text] [Related]
54. The redox switch/redox coupling hypothesis.
Cerdán S; Rodrigues TB; Sierra A; Benito M; Fonseca LL; Fonseca CP; García-Martín ML
Neurochem Int; 2006; 48(6-7):523-30. PubMed ID: 16530294
[TBL] [Abstract][Full Text] [Related]
55. Oligodendrocyte gap junction loss and disconnection from reactive astrocytes in multiple sclerosis gray matter.
Markoullis K; Sargiannidou I; Schiza N; Roncaroli F; Reynolds R; Kleopa KA
J Neuropathol Exp Neurol; 2014 Sep; 73(9):865-79. PubMed ID: 25101702
[TBL] [Abstract][Full Text] [Related]
56. Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque.
Raine CS; Bonetti B; Cannella B
Rev Neurol (Paris); 1998 Sep; 154(8-9):577-85. PubMed ID: 9809372
[TBL] [Abstract][Full Text] [Related]
57. Association of Parkinson disease-related protein PINK1 with Alzheimer disease and multiple sclerosis brain lesions.
Wilhelmus MM; van der Pol SM; Jansen Q; Witte ME; van der Valk P; Rozemuller AJ; Drukarch B; de Vries HE; Van Horssen J
Free Radic Biol Med; 2011 Feb; 50(3):469-76. PubMed ID: 21145388
[TBL] [Abstract][Full Text] [Related]
58. Absence of aquaporin-4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter.
Sinclair C; Kirk J; Herron B; Fitzgerald U; McQuaid S
Acta Neuropathol; 2007 Feb; 113(2):187-94. PubMed ID: 17143632
[TBL] [Abstract][Full Text] [Related]
59. Immunohistochemical detection of sphingosine-1-phosphate receptor 1 and 5 in human multiple sclerosis lesions.
Brana C; Frossard MJ; Pescini Gobert R; Martinier N; Boschert U; Seabrook TJ
Neuropathol Appl Neurobiol; 2014 Aug; 40(5):564-78. PubMed ID: 23551178
[TBL] [Abstract][Full Text] [Related]
60. Differential lowering by manganese treatment of activities of glycolytic and tricarboxylic acid (TCA) cycle enzymes investigated in neuroblastoma and astrocytoma cells is associated with manganese-induced cell death.
Malthankar GV; White BK; Bhushan A; Daniels CK; Rodnick KJ; Lai JC
Neurochem Res; 2004 Apr; 29(4):709-17. PubMed ID: 15098932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
